$20.38
-1.26-5.82%
Last update: Oct 16, 3:17 PM
$21.61
-0.03-0.14%
Mineralys Therapeutics Inc
MLYSNASDAQ
Mineralys Therapeutics (MLYS) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.54 | $-0.45 | $-0.54 | $-0.63 |
| Actual | $-2.85 | $-0.47 | $-0.40 | $-0.52 |
| Surprise | -427.8% | -4.44% | +25.9% | +17.5% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | — | — | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.54 | $-0.59 |
| Revenue | ||
| Consensus | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-2.85 | $-0.54 | -427.8 % |
| Q1 | May 6, 2026 | $-0.47 | $-0.45 | -4.44 % |
| Q4 | Mar 12, 2026 | $-0.40 | $-0.54 | 25.9 % |
| Q3 | Nov 10, 2025 | $-0.52 | $-0.63 | 17.5 % |
